Filters

Anti-ACBD3/GOCAP1 (Polyclonal), ALEXA Fluor 594

Anti-ACBD3/GOCAP1 (Polyclonal), ALEXA Fluor 594 size: 100 microliters 489

Price 489
Size 100 microliters
TypeConjugated Primary Antibody
Conjugated with 594, ALEXA FLUOR®
Host organismRabbit (Oryctolagus cuniculus)
Target Protein/PeptideACBD3/GOCAP1
SpecificityThis antibody reacts specifically with ACBD3/GOCAP1
ModificationNo modification has been applied to this antibody
Modification siteNone
ClonalityPolyclonal Antibody
ClonePolyclonal Antibodies
Concentration1ug per 1ul
Subcellular locationsN/A
Antigen SourceKLH conjugated synthetic peptide derived from human ACBD3/GOCAP1
Gene IDN/A
Swiss ProtN/A
ApplicationsIF(IHC-P)
Applications with corresponding dilutionsIF(IHC-P)(1:50-200)
Cross reactive species Rat (Rattus norvegicus), Human (Homo sapiens)
Cross Reactive Species details However, note that due to limited knowledge it is impossible to predict with 100% guarantee that the antibody does not corss react with any other species, No significant cross reactivity has been observed for this antibody for the tested species
Background information ACBD3 is responsible for maintaining Golgi structure and, ACBD3 is thought to act as a peripheral-type benzodiazepine receptor-associated protein, Additionally, Changes in the subcellular location of ACBD3 trigger signaling cascades within the Golgi that regulate cell fate and cell cycle progression, Expressed ubiquitously with highest expression in ovary and testis, GOCAP1, PAP7 or GOLPH1, also known as GCP60 (Golgi resident protein GCP60), functions to mediate protein transport between the Golgi and the endoplasmic reticulum (ER), is a Golgi apparatus membrane protein that contains one ACB (acyl-CoA-binding) domain and one GOLD (Golgi dynamics) domain which is essential for its interaction with other proteins, possibly playing a role in hormonal regulation and steroid formation, through binding to Giantin (golgin subfamily B member 1), ACBD3 (acyl-CoA-binding domain-containing protein 3)
Purification methodPurified by Protein A
Storage 50% glycerol and 0, Store at 4°, 09% sodium azide, C for 12 months, Water buffered solution containing 100ug/ml BSA
Excitation emission590nm/617nm
Synonyms GCP60 PAP7
Also known asACBD3/GOCAP1 Polyclonal Antibody
Other nameAnti-ACBD3/GOCAP1 Polyclonal
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, specificity and sensitivity, thus reducing its reactivity, Avoid freeze/thaw cycles as they may denaturate the polypeptide chains of the antibody
PropertiesFor facs or microscopy Alexa 1 conjugate
ConjugationAlexa Fluor
GroupPolyclonals and antibodies
About The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot
Gene targetACBD3/GOCAP1
Short nameAnti-ACBD3/GOCAP1 (Polyclonal) Fluor 594
Technique Pabs are a collection of immunoglobulin , Polyclonal antibodies , each identifying a different , whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different 
LabelALEXA
Alternative name ALEXA Fluor 594, antibody to-ACBD3/GOCAP1 (polyclonal)
Alternative techniquepolyclonals
Identity 15453
Gene ACBD3
Long gene name acyl-CoA binding domain containing 3
Synonyms gene GOLPH1 GOCAP1
Synonyms gene name 60kDa acyl-Coenzyme A binding domain containing 3 , golgi complex associated protein 1
Synonyms name PBR- and PKA-associated protein 7
Locus 1q42, 12
Discovery year 2001-04-27
GenBank acession AB043587
Entrez gene record 64746
Pubmed identfication 12692076 20150326
RefSeq identity NM_022735
Classification A-kinase anchoring proteins
Havana BLAST/BLAT OTTHUMG00000037560

Subscribe to our Newsletter